SteroTherapeutics Competitors and Similar CompaniesClear all
SteroTherapeutics's competitors and similar companies include Albireo Pharma, Heron Therapeutics, United Biomedical and Ventria Bioscience.
 SteroTherapeutics SteroTherapeutics is a biopharmaceutical company developing therapies for diseases related to metabolic syndrome. |  Albireo Pharma Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. |  United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. |  Ventria Bioscience Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases. | |
Founding Date | Founding Date 2016 | Founding Date 2003 | Founding Date 1983 | Founding Date 1985 | Founding Date 1993 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Doylestown, US HQ | Locations Boston, US HQ Göteborg, SE | Locations San Diego, US HQ | Locations Junction City, US HQ Aurora, US | |
Employees | Employees N/A | Employees 5541% increase | Employees 20333% decrease | Employees 45 | Employees 244% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 915.9 m | Valuation ($) 268.5 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $40.6m (FY, 2021) | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.4m (FY, 2021) | Cost of goods $41.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $39.2m (FY, 2021) | Gross profit $113.6m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($34m) (FY, 2021) | Net income ($20.2m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 40m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.7m |
For sources of this data, please see the company profile
View Company Profiles
Albireo Pharma
HQ
Boston, US
Employees
55↑ 41% increase
Albireo, a biotechnology company, develops therapeutic drugs for gastrointestinal diseases.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View companyUnited Biomedical
HQ
Hauppauge, US
Employees
45
United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
View companyVentria Bioscience
HQ
Junction City, US
Employees
24↓ 4% decrease
Ventria Bioscience develops life-saving medicines targeting inflammatory, infectious and gastrointestinal diseases.
View company